HUMAN HEART TISSUE FOR DRUG DISCOVERY
The human heart is a complex organ of distinct sub-structures, different tissue types and cellular architectures that work in a coordinated fashion to pump blood throughout the body (Figure 1). Tissue distribution, cellular composition and gene expression vary throughout the heart to match regional function. Such organ complexity is precisely why AnaBios offers a suite of anatomically distinct human tissue samples that cover the breadth of cardiac functions (Table 1).
Figure 1. Schematic of the human heart
Table 1. AnaBios Human Cardiac Tissue Areas
Aortic Semilunar Valve
Pulmonary Semilunar Valve
Ventricular Outflow Tract
DOWNLOAD HUMAN HEART TISSUE CATALOG
USING HUMAN CARDIAC TISSUE FOR HEART FAILURE & CARDIOTOXICITY RESEARCH
Heart failure remains a leading cause of death and cardiotoxicity is a major contributor to late-stage failures in drug development. High-quality human cardiac tissue samples provide a strong translational foundation for ensuring appropriate therapeutic target expression and localization while providing insight as to potential toxic interactions and safety concerns.
AnaBios has been enabling clinical success with high quality cardiac tissue samples precisely matched and prepared to individual program needs for over 11 years. Let us jump-start your success with both healthy and diseased human heart tissue samples.
QUALITY IS KEY: THE ANABIOS ADVANTAGE
The AnaBios Advantage minimizes ischemic/reperfusion injury to provide the highest quality tissue samples for the most accurate and translatable results. Tissue sample quality is exemplified in two primary areas.
First is the ability of AnaBios to provide functional cardiac assays as outlined by our CardioPRIME® and other functional offerings. Second is the industry-leading RNA integrity number (RIN) scores. The AnaBios Advantage and quality systems ensure tissues samples with consistently high RIN scores across donors. Starting with high-quality data enables the highest quality results.
HEALTHY & DISEASED HUMAN HEART TISSUE
Different Formats to Meet Drug Discovery Program Needs
AnaBios provides a variety of fixed and frozen off-the-shelf human tissue samples from our biorepository, as well as proactive custom recoveries from healthy and diseased organ donors. Table 2 below is a non-exclusive listing of tissue types and structures.
AnaBios prepares tissue samples for downstream omics work, immunocytochemistry, in-situ hybridization and more. Contact us for additional information on donor demographics and sample types from heart failure, atrial fibrillation, hypertrophic cardiomyopathy, coronary artery disease and other heart conditions.
Table 2: Human Heart Tissue Types & Structures
HEART TISSUE TYPE
Ventricular (left & right chambers)
Myocardial musculature, papillary muscle, Purkinje fibers, trabeculae, ventricular outflow tracts
Atrial (left & right chambers)
Myocardial musculature, Purkinje fibers, right and left appendages, trabeculae
Artery, aorta, brachiocephalic, carotid, circumflex, subclavian vein, coronary (ascending & descending), pulmonary
Aortic, aortic semilunar, bicuspid, mitral, pulmonary semi-lunar
ACCESS OUR HEART RESEARCH WEBINARS
Dr. Najah Abi-Gerges, Vice President of Research & Development at AnaBios, demonstrates how human primary cardiomyocytes can be used to predict inotropes. This novel platform can be used to enhance drug discovery programs and better guide decision-making.
Get access to more cardiac research webinars, as well as poster, publications and brochures, in our library. Click on the button to the right to access it.
MORE CARDIAC RESEARCH WEBINARS
- Luo et al. (2021) Nature Scientific Reports Chamber-enriched gene expression profiles in failing human hearts with reduced ejection fraction https://www.nature.com/articles/s41598-021-91214-2
- Okada et al (2022) Biomolecules Comparative Study of Transcriptome in the Hearts Isolated from Mice, Rats, and Humans https://www.mdpi.com/2218-273X/12/6/859
- Kifoil et al. (2021) European Journal of Pharmacology Characterization of a high throughput human stem cell cardiomyocyte assay to predict drug-induced changes in clinical electrocardiogram parameters https://www.sciencedirect.com/science/article/pii/S0014299921007408
HAVE MORE QUESTIONS?
To inquire about products, services and pricing, please go to the ‘Contact Us’ page by clicking the button below.